Chase AIPricingFAQs
Display currency
Loading news…

Propellon Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Toronto, Ontario, Canada Founded 2016 1-10 employees For Profit

Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Patents
3

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Patents granted
3
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene

Company Info

Founded
2016
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
HQ
Toronto, Ontario, Canada
Region
Great Lakes

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0
Trend (30d)
0
Trend (90d)
0

Key People at Propellon Therapeutics

Vice-President

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Propellon Therapeutics

Loading news…

FAQs about Propellon Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Propellon Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments